Freestone Grove Partners’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47M Buy
1,861,677
+869,831
+88% +$20.6M 0.3% 93
2026
Q1
$21.7M Buy
991,846
+376,451
+61% +$8.73M 0.15% 200
2025
Q4
$14.3M Buy
615,395
+565,845
+1,142% +$13.6M 0.1% 247
2025
Q3
$1.4M Sell
49,550
-96,219
-66% -$2.56M 0.01% 402
2025
Q2
$3.21M Buy
145,769
+121,681
+505% +$2.66M 0.02% 347
2025
Q1
$561K Sell
24,088
-7,913
-25% -$202K 0.01% 397
2024
Q4
$919K Buy
+32,001
New +$958K 0.01% 308

Other funds holding GNTX

Freestone Grove Partners's GNTX Position: Q2 2026 in Review

Freestone Grove Partners increased its Gentex (GNTX) stake by 88% in Q2 2026, buying an estimated $20.6M and bringing the position to 1,861,677 shares worth $47M. The position accounts for 0.3% of the portfolio, ranked #93.

Freestone Grove Partners first reported a position in GNTX in Q4 2024 and has held it in 7 quarters since. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Freestone Grove Partners held 1,861,677 shares of Gentex worth $47M as of Q2 2026.
  • Freestone Grove Partners bought 869,831 Gentex shares in Q2 2026, an estimated $20.6M.
  • Gentex made up 0.3% of Freestone Grove Partners's portfolio in Q2 2026, its #93 holding.
  • Freestone Grove Partners first reported a position in Gentex in Q4 2024 and has held it in 7 quarters since.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.